BEAMSTART Logo

HomePeopleProfile

Dalibor Sames

Founder, Gilgamesh Pharmaceuticals 


Join Date

October 2024

Gender

Not Specified

Age

Not Specified


About Dalibor Sames

Professor of Chemistry at Columbia University with expertise in synthetic chemistry, medicinal chemistry, molecular design, synaptic imaging, neuropharmacology, and experimental therapeutics. Led new conceptual advances in chemical synthesis (C-H bond functionalization), developed fluorescent false neurotransmitters (FFNs), elucidated the mechanism of action of antidepressant tianeptine, expertise in iboga alkaloid and mitragynines chemistry and pharmacology.

Companies & Work

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Share This Profile

Featured Members from United States

Varand Abadi

CEO of Fanclan

Josh Kerber

Co-founder of BidSight

Daniel Cahn

CEO of Slingshot AI

Connor Janson

Co-founder of BidSight

David Huie

CEO of Vibrato

Cristian Bodnar

Founder, Silurian

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.